Skip to content
Stock screener

ZTS Zoetis Inc. stock chart & analysis

Conviction 47HealthcareScan · Fri, Nov 6, 2026

Zoetis Inc. (ZTS) closed at $79.40 (-3.30%) on Nov 6, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 51, RS Rating 24, -40.1% from its 52-week high, -36.9% year to date. Sector: Healthcare · Pharmaceutical Preparations.

ZTS$79.40-3.30%
ResistanceSupportVol 14Insider buyCongress buyCongress sell
Loading chart…
Zoetis Inc.Pharmaceutical Preparationswww.zoetis.com ↗
Price79.40
Change-3.30%
Gap-3.11%
Rel volume1.91×
Avg volume4.59M
Avg $ vol369.94M
SMA 2079.89
SMA 5075.69
SMA 20092.50
Price vs 50+4.94%
Price vs 200-14.13%
MA stackmixed
50/200 cross—
Supertrenddown · 88.68
RSI (14)51
MACD hist0.09
MACD cross—
Stoch %K / %D20 / 53
ADX (14)34
+DI / −DI34 / 24
RSI divergence—
MACD divergence—
ATR %3.44%
ADR %2.76%
52w high132.49
52w low68.77
From 52w high-40.05%
Above 52w low+15.50%
New 52w highNo
SqueezeOff
Bollinger width15.85%
%B0.46
Donchian pos34.79%
Donchian high89.29
Donchian low74.17
AVWAP (52w high)86.65
vs AVWAP high-8.34%
AVWAP (52w low)78.63
vs AVWAP low+1.01%
OBV trendFlat
Chaikin MF (20)0.17
Today vs 20d1.91×
Avg vol (14d)4.75M
Avg vol (20d)4.59M
Avg $ vol (20d)369.94M
Market cap32.27B
RS Rating24 / 99
RS 3m (vs SPY)+11.02%
RS 6m (vs SPY)-3.80%
RS line new highNo
Trend template2/8
Technical rank61.8
1 week-0.36%
1 month+8.69%
3 months+6.15%
6 months-4.10%
1 year-34.08%
YTD-36.87%
P/E12.07
P/B9.77
P/S3.41
P/FCF14.14
EPS6.02
Div yield—
ROE80.93%
ROA17.72%
Debt/Eq2.74
Current2.35
EV/EBITDA—
Gross margin71.84%
Net margin28.23%
Rev growth2.28%
EPS growth7.52%
Price target87.90
Target upside10.66%
Analyst ratingHold
Institutional109.29%
Ent. value39.99B
Revenue2.39B
Net income591M
Gross profit1.69B
Free cash flow2.28B
IndustryPharmaceutical Preparations
ExchangeNYSE
Shares out—
Employees14.5K
ListedFri, Feb 1, 2013
Free float383.83M
Float %91.3%
Short interest—
Days to cover—
Short volume41.6%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$1.75 vs $1.51
Last surprise+15.9% beat
Setup gradeD
Conviction47 / 100
Pattern quality—
Tech rank61.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance85.79
Support69.15
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

ZTS technical analysis

Trend

ZTS's moving averages are mixed — no clean uptrend or downtrend. It closed 4.9% above the 50-day ($75.69) and 14.1% below the 200-day ($92.50). ADX(14) at 34 points to a strong, established trend. It meets 2 of 8 trend-template criteria.

Momentum

RSI(14) is 51, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 24 puts its weighted 12-month performance ahead of about 24% of the US market.

Volume and volatility

Volume on the latest session ran 1.9× its 20-day average. It trades about $369.9M a day on average. ATR(14) is $2.73, 3.4% of price — its typical daily range. Chaikin Money Flow (0.17) shows accumulation.

Key levels

The chart pattern's support is $69.15 and its resistance $85.79. The 52-week range is $68.77 to $132.49; price is 40.1% below the high and 15.5% above the low. The VWAP anchored at the 52-week high is $86.65, above price.

Performance

ZTS returned -0.4% (1 week), +8.7% (1 month), +6.2% (3 months), -4.1% (6 months), -34.1% (1 year), -36.9% (year to date).

About Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Pharmaceutical Preparations · Listed 2013 · 14,500 employees

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 21 – Oct 9
    4 scans
  2. Breaking out now
    Oct 12
    1 scan
  3. Setting up
    Oct 13
    1 scan
  4. Breaking out now
    Oct 14
    1 scan
  5. Broke out
    Oct 15 – Oct 19
    3 scans
  6. Setting up
    Oct 29 – Oct 30
    2 scans

Congress activity

Disclosed STOCK Act trades in ZTS · 10 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-09-18
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-07-17
Sell$1K–$15K
Byron Donalds
Byron Donalds
house · R · FL · traded 2026-06-09
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-06-16
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-11-18
Buy$1K–$15K
Markwayne Mullin
Markwayne Mullin
senate · traded 2025-11-10
Sell$15K–$50K
Rick Larsen
Rick Larsen
house · D · WA · traded 2025-10-06
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-08-04
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-05
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-01-15
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in ZTS

InsiderSideShares
Stetter Mark
Director · Phantom Stock Unit · 2026-10-30
Grant5.852
SACCARO JAMES
EVP, CFO & COO · Restricted Stock Unit · 2026-08-31
Grant81.06K
DAMELIO FRANK A
Director · Common Stock · 2026-08-07
Gift6.65K
Stetter Mark
Director · Phantom Stock Unit · 2026-06-18
Grant317.622
Stetter Mark
Director · Restricted Stock Unit · 2026-05-21
Other—
Stetter Mark
Director · Restricted Stock Unit · 2026-05-21
Exercise1.57K
Stetter Mark
Director · Common Stock · 2026-05-21
Exercise1.57K
PARENT LOUISE M
Director · Common Stock · 2026-05-20
Exercise10.19K
PARENT LOUISE M
Director · Restricted Stock Unit · 2026-05-20
Exercise1.94K
PARENT LOUISE M
Director · Common Stock · 2026-05-20
Exercise1.94K

SEC filings

EDGAR filings in ZTS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.